Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Nov;32(11):1220-1227.
doi: 10.1007/s11606-017-4151-6. Epub 2017 Aug 14.

Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study

Affiliations
Observational Study

Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study

Maria E Montez-Rath et al. J Gen Intern Med. 2017 Nov.

Abstract

Background: There is little information on hospital and nursing facility stays during the transition from pre-dialysis kidney disease to end-stage renal disease treated with dialysis.

Objectives: To examine hospital and nursing facility stays in the years pre- and post-dialysis initiation, and to develop a novel method for visualizing these data.

Design: Observational study of patients in the US Renal Data System initiating dialysis from October 2011 to October 2012.

Participants: Patients aged ≥67 years with Medicare Part A/B coverage for 1 year pre-dialysis initiation.

Main measures: Proportion of patients with ≥1 facility day, and among these, the mean number of days and the mean proportion of time spent in a facility in the first year post-dialysis initiation. We created "heat maps" to represent data visually.

Key results: Among 28,049 patients, > 60% initiated dialysis in the hospital. Patients with at least 1 facility day spent 37-42 days in a facility in the year pre-dialysis initiation and 59-67 facility days in the year post-dialysis initiation. The duration of facility stay varied by age: patients aged 67-70 years spent 60 (95% CI 57-62) days or 25.8% of the first year post-dialysis initiation in a facility, while patients aged >80 years spent 67 (CI 65-69) days or 36.8% of the first year post-dialysis initiation in a facility. Patterns varied depending on the presence or absence of certain comorbid conditions, with dementia having a particularly large effect: patients with dementia spent approximately 50% of the first year post-dialysis initiation in a facility, regardless of age.

Conclusions: Older patients, particularly octogenarians and patients with dementia or other comorbidities, spend a large proportion of time in a facility during the first year after dialysis initiation. Our heat maps provide a novel and concise visual representation of a large amount of quantitative data regarding expected outcomes after initiation of dialysis.

Keywords: dialysis; hospitalization; kidney failure; nursing facility.

PubMed Disclaimer

Conflict of interest statement

Disclaimer

This work was conducted under a data use agreement between Dr. Chang and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). An NIDDK officer reviewed this manuscript for research compliance and approved of its submission for publication. Data reported herein were supplied by the USRDS. Interpretation and reporting of these data are the responsibility of the authors and should in no way be seen as official policy or interpretation of the US government.

Funders

Dr. Chang is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; 5K23DK095914). Dr. Montez-Rath and Dr. Kurella Tamura are supported by grant U01DK102150 from the NIDDK.

Prior Presentations

A portion of this work was presented at the American Society of Nephrology Kidney Week 2016, Chicago, IL.

Conflict of Interest

MMR, YZ, and VG report no conflicts of interest.

MKT reports receiving honoraria from US Renal Care.

WCW has received consulting fees from AMAG, Akebia, Amgen, AstraZeneca, Bayer, Daichii Sankyo, Fibrogen, Medtronic, Relypsa, and Vifor FMC Renal Pharma.

TIC has received consulting fees from Janssen Research and Development, LLC.

Figures

Figure 1
Figure 1
Schematic representation of the “heat map.” For illustrative purposes, the schematic shows only 3 days pre-dialysis initiation and 10 days post-dialysis initiation for five hypothetical patients, while the actual heat maps extend to 120 days pre-dialysis and 365 days post-dialysis initiation. Each day is represented by a single box that is color-coded as indicated in the legend. Each patient is represented by one row in the heat map. For example, patient (Pt) 1 spent the 3 days pre- and 10 days post-dialysis initiation at home. Patient 2 had no facility days pre-dialysis initiation, was hospitalized at the time of dialysis initiation, and then spent 2 days in a nursing facility before going home. Patients 3 and 4 spent variable lengths of time in a facility before dying on days 10 and 7 post-dialysis initiation, respectively. Patient 5 was hospitalized from 3 days pre- through 4 days post-dialysis initiation before dying on day 5 post-dialysis initiation.
Figure 2
Figure 2
Heat maps showing the status of patients aged a) 67–70 years, b) 71–75 years, c) 76–80 years, and d) >80 years during the 120 days pre- and 365 days post-dialysis initiation. *Post-dialysis initiation.
Figure 3
Figure 3
Heat maps showing the status of patients aged 67–70 years a) without cardiovascular disease (CVD) and b) with CVD, and patients aged >80 years c) without CVD and d) with CVD, during the 120 days pre- and 365 days post-dialysis initiation. ^In the 365 days post-dialysis initiation. *Post-dialysis initiation.
Figure 4
Figure 4
Heat maps showing the status of patients aged 67–70 years a without dementia and b with dementia, and patients aged >80 years c without dementia and d with dementia, during the 120 days pre- and 365 days post-dialysis initiation. *Post-dialysis initiation.

References

    1. United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2016.
    1. Jassal SV, Chiu E, Hladunewich M. Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med. 2009;361(16):1612–3. doi: 10.1056/NEJMc0905289. - DOI - PubMed
    1. Bowling CB, Plantinga L, Hall RK, Mirk A, Zhang R, Kutner N. Association of nondisease-specific problems with mortality, long-term care, and functional impairment among older adults who require skilled nursing care after dialysis initiation. Clin J Am Soc Nephrol. 2016;11(12):2218–24. doi: 10.2215/CJN.01260216. - DOI - PMC - PubMed
    1. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007;146(3):177–83. doi: 10.7326/0003-4819-146-3-200702060-00006. - DOI - PubMed
    1. Verberne WR, Geers AB, Jellema WT, Vincent HH, van Delden JJ, Bos WJ. Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis. Clin J Am Soc Nephrol. 2016;11(4):633–40. doi: 10.2215/CJN.07510715. - DOI - PMC - PubMed

Publication types